Related by context. All words. (Click for frequent words.) 76 Prolongs Survival 75 Clinical Trial Results 75 Protease Inhibitor 75 Combination Treatment 75 Meets Primary Endpoint 74 HCV Protease Inhibitor 74 Antitumor Activity 74 Chronic Hepatitis C 74 Phase 2b Clinical Trial 74 Long Term Efficacy 73 Completes Patient Enrollment 73 Drug Candidate 73 Antiviral Activity 73 Oral Fingolimod 73 Investigational Compound 73 Preclinical Data 73 Study Evaluating 73 Phase 2a Trial 73 Phase 2b Trial 73 Novel Antibiotic 73 Novel Oral 73 Demonstrates Potent 73 Phase IIb Clinical Trial 72 JAK Inhibitor 72 Investigational Drug 72 Tolerability 72 Presents Positive 72 Initiate Phase 72 Investigational Treatment 72 Immunogenicity 72 Patients Treated With 72 Anti Tumor Activity 72 Gout Drug 72 Vitro Activity 72 Survival Benefit 72 Pooled Analysis 72 Phase IIb Trial 72 Treated Patients 72 Lupus Drug 72 RNAi Therapeutic 72 Fungal Infections 72 Novel Mechanism 72 Demonstrates Efficacy 72 Rotavirus Vaccine 71 Clinical Trial Data 71 Presents Preclinical Data 71 Initiates Clinical 71 Hepatitis B Vaccine 71 Previously Treated 71 Phase III Trial 71 Submits NDA 71 Relapsing Multiple Sclerosis 71 Adjunctive Therapy 71 Anticancer Activity 71 Anticancer Drug 71 Seasonal Influenza Vaccine 71 Treating Chronic 71 Single Dose 71 Vaccine Protects Against 71 Receives Approvable Letter 71 Anti Tumor 71 Phase III Clinical Trial 71 Polymerase Inhibitor 71 Milestone Payment 71 IND Application 71 Therapeutic Vaccine 71 Pharmacokinetic Study 71 Antitumor 71 Well Tolerated 71 Vicriviroc 71 Kinase Inhibitor 71 Prostate Cancer Vaccine 71 Receives Orphan Drug Designation 71 Infected Patients 71 Initiates Clinical Trial 70 Hematological Malignancies 70 Improves Survival 70 Pediatric Patients 70 Present Preclinical Data 70 Shows Promise Against 70 Demonstrates Significant 70 Initiates Phase III 70 FDA Accepts 70 See CLINICAL PHARMACOLOGY 70 Insulin Glargine 70 FDA Approvals 70 Immunomedics Announces 70 Phase 2a Clinical Trial 70 Psoriasis Drug 70 Renal Cancer 70 Acute Heart Failure 70 Kinase Inhibitors 70 Improves Outcomes 70 Prophylactic Treatment 70 Clostridium difficile Infection 70 Epilepsy Drug 70 II Clinical Trial 70 Immunotherapeutic 70 Controlled Trial 70 Initiates Phase II 70 Cholesterol Lowering Drug 70 Double Blind Placebo 70 Shows Efficacy 70 Expanded Indication 70 Phase 2b Study 70 Migraine Drug 70 Hematological Cancers 70 Severe Sepsis 70 Receives Milestone Payment 70 Peginterferon 70 Treatment Naïve 70 Statistically Significant 70 Begin Clinical Trials 70 Drug Shows Promise 70 Demonstrates Sustained 69 Chronic Hepatitis B 69 Antifungal 69 Lung Cancer Drug 69 Vaccine Candidate 69 Pivotal Phase III 69 Randomized Phase 69 Capsules CII 69 Schizophrenia Drug 69 Drug Combo 69 Renal Cell Carcinoma 69 Completes Enrollment 69 Pulmonary Arterial Hypertension 69 Systemic Delivery 69 First Patient Dosed 69 Appears Safe 69 Clinical Efficacy 69 Successfully Completes Phase 69 Newly Diagnosed Multiple Myeloma 69 Clinical Outcome 69 Inflammatory Diseases 69 Inflammatory Arthritis 69 Monoclonal Antibody 69 Dose Ranging Study 69 Dose Escalation 69 Oral Presentations 69 Patients Receiving 69 Sustained Efficacy 69 Mylan Receives Approval 69 Pivotal Phase 69 Crit Rev 69 Faropenem 69 Myeloma Patients 69 Multiple Myeloma Patients 69 Shows Promising 69 Hepatitis C Genotype 69 Fast Track Status 69 Preclinical Study 69 Rheumatoid Arthritis Drug 69 Phase III Trials 69 Demonstrates Positive 69 Novel Therapies 69 Integrase Inhibitor 69 Glufosfamide 69 Advanced Melanoma 69 Nitazoxanide 69 Treatment Experienced 69 Osteoporosis Treatment 69 Significantly Improved 69 Patient Enrollment 69 Arthritis Drug 69 PRN FDA Approves 69 HDAC Inhibitor 69 ISTODAX ® 69 Metastatic Colorectal Cancer 69 Parathyroid Hormone 69 Antiviral Drugs 69 Pegylated Interferon 69 Trial Evaluating 69 BioSante Pharmaceuticals Announces 69 Initiates Enrollment 69 Adjuvant Chemotherapy 68 Teva Provides Update 68 Glatiramer Acetate 68 Diabetic Neuropathy 68 Demonstrates Ability 68 Initiate Phase III 68 Drug Resistant 68 Files IND 68 Kidney Function 68 Benign Prostatic Hyperplasia 68 Orally Active 68 Pneumococcal Vaccine 68 Begins Dosing 68 Overactive Bladder 68 Meta Analysis 68 Treatment Naive Patients 68 Hepatotoxicity 68 Immune Responses 68 Randomized Double Blind 68 Systemic Sclerosis 68 Kidney Transplant Patients 68 PDUFA Date 68 Anticoagulant 68 Late Breaker 68 Small Molecule 68 Low Dose 68 Interferon Alpha 68 Demonstrates Statistically Significant 68 Pivotal Study 68 Atypical Antipsychotic 68 Combination REOLYSIN R 68 Patients Treated 68 NDA Submission 68 Randomized Clinical Trials 68 Moxifloxacin 68 Tolerability Study 68 Phase IIa Clinical Trial 68 Drug Fails 68 Injection Site 68 Study Showed 68 Advanced Prostate Cancer 68 Vaccine Adjuvant 68 Proven Effective 68 Osteoporosis Drug 68 JAK2 Inhibitor 68 Monotherapy 68 Generic Versions 68 Confirmatory Phase 68 Mouse Model 68 RNAi Therapeutics 68 Recombinant Human 68 Placebo Controlled Trial 68 Resistant Hypertension 68 Protease Inhibitors 68 Acute Ischemic Stroke 68 Dual Antiplatelet Therapy 68 Improved Survival 68 Preclinical Models 68 Hsp# Inhibitor 68 FDA Clears 68 Disease Modifying 68 Myelodysplastic Syndromes 68 Malaria Vaccine 68 Anemia Drug 68 Tezampanel 68 ARIXTRA R 68 Colorectal Cancer Patients 68 Develops Novel 68 Avian Flu Vaccine 68 Controlled Study 68 Beneficial Effects 68 Interferon Beta 68 Biomarker Study 68 Elderly Patients 68 Hepatitis C Virus 67 FDA APPROVES 67 Achieves Primary Endpoint 67 Ozarelix 67 Tumor Targeting 67 Tyrosine Kinase Inhibitor 67 Intravenous Formulation 67 Peginterferon Alfa 2a 67 Antidepressant Drug 67 Receives Fast Track 67 Gastric Cancer 67 Fabry Disease 67 Rheumatoid Arthritis Patients 67 Atopic Dermatitis 67 Advanced Pancreatic Cancer 67 Adjuvant Treatment 67 Hepatitis B Virus 67 Relapsed Multiple Myeloma 67 Fluconazole 67 Previously Untreated 67 Sirolimus Eluting Stent 67 Combo Therapy 67 Smallpox Vaccine 67 Data Suggest 67 Hospital Acquired Pneumonia 67 Eszopiclone 67 Significant Reduction 67 Reports Preclinical Data 67 Complicated Skin 67 Epratuzumab 67 Fondaparinux 67 Novel Therapeutic 67 Transdermal Patch 67 Inflammatory Markers 67 Unfractionated Heparin 67 Randomized Trials 67 Predict Response 67 Improve Survival 67 Patients Enrolled 67 Romidepsin 67 First Patient Treated 67 Tipranavir 67 Mg Usa 67 Romiplostim 67 Septic Shock 67 First Patient Enrolled 67 Fixed Dose 67 Humanized Anti 67 Respiratory Virus 67 Multicenter Phase 67 Tigecycline 67 IND Filing 67 Therapeutic Vaccines 67 Cethromycin 67 Metastatic Melanoma 67 Thiovir 67 Drug Formulation 67 Successfully Treated 67 Showed Significant 67 Treatment Regimen 67 Demonstrated Significant 67 Desvenlafaxine Succinate 67 Randomized Clinical Trial 67 Partial Onset Seizures 67 Efficacy Trial 67 Anticancer Drugs 67 Nicotine Vaccine 67 Vildagliptin 67 Cypher Sirolimus 67 Effectively Treats 67 Extended Release 67 Phase Ib Clinical Trial 67 Influenza Vaccine 67 Lung Cancer Survival 67 TB Vaccine 67 Study Shows Benefits 67 FDA Okays 67 Anti Inflammatory Drug 67 Confirms Efficacy 67 Combination Therapy 67 Shingles Vaccine 67 Demonstrate Significant 67 Mycophenolate Mofetil 67 Invasive Fungal Infections 67 Dendritic Cells 66 Immunomodulatory 66 Drug Eluting 66 Adefovir 66 Interferon Gamma 66 Efficacious 66 Nebulized 66 Therapeutic Antibody 66 Attenuates 66 Lupus Nephritis 66 Receives Orphan Drug 66 Hepatocellular Carcinoma 66 Telbivudine 66 Disease Progression 66 Therapy Improves 66 Inhaled Liposomal Ciprofloxacin 66 Anti Clotting Drug 66 Plaque Psoriasis 66 Antiviral Therapy 66 Aliskiren 66 Allergic Rhinitis 66 Hormone Refractory Prostate Cancer 66 Synthetic Peptide 66 Sapacitabine 66 Treatment Shows Promise 66 Generic Version 66 Hedgehog Pathway Inhibitor 66 Antiangiogenic 66 R lenalidomide 66 Diabetic Nephropathy 66 Pivotal Trials 66 Antipsychotic 66 Guidelines Issued 66 Poster Presentations 66 Subgroup Analysis 66 Proves Effective 66 Cancer Stem Cells 66 Therapeutic Potential 66 Nucleoside 66 Antifungals 66 Kidney Transplant Recipients 66 Vaccine Adjuvants 66 Blood Thinner 66 Inhaled Insulin 66 HER2 Positive 66 Angiogenic 66 Plus Ribavirin 66 Milestone Payments 66 Bare Metal Stents 66 Pharmacokinetic Profile 66 Oral Insulin 66 Antiviral Drug 66 Drug Prevents 66 Aflibercept 66 NMDA Receptor 66 Collaborators Present 66 Venous Thromboembolism 66 SPRYCEL ® 66 Fewer Side Effects 66 Nymox NX 66 Refractory Hodgkin Lymphoma 66 Cholesterol Drug 66 Prognostic Value 66 Novel Compound 66 Abstract Accepted 66 Preclinical Evaluation 66 Novel Small Molecule 66 Significantly Reduces 66 Tablet Formulation 66 Anti Angiogenic 66 Heart Failure Patients 66 Epidermal Growth Factor Receptor 66 Initiates Dosing 66 Tumor Growth 66 Is Well Tolerated 66 Pharmacokinetics PK 66 Non Invasive Treatment 66 Taxane 66 Autologous Stem Cell Transplantation 66 Relapsed Refractory 66 Itraconazole 66 Granted Orphan Drug 66 Spectrum Pharmaceuticals Announces 66 Aurora Kinase 66 Cardiotoxicity 66 Phase 1b Clinical Trial 66 Phase III Clinical Trials 66 Prognostic Factors 66 Anthracycline 66 adalimumab Humira 66 Oral Calcitonin 66 Tesamorelin 66 Oncolytic 66 Adjuvant Therapy 66 ORENCIA ® 66 Hypertensive Patients 66 Pazopanib 66 Hormone Receptor Positive 66 Enzyme Replacement Therapy 66 Schizophrenia Treatment 66 NICE Recommends 66 Novel Treatments 66 Pegylated 66 Significantly Reduced 66 Slow Progression 66 Blood Pressure Drug 66 Commonly Used 66 Unresectable 66 Critically Ill Patients 66 Pivotal Trial 66 Investigational Agent 66 Phase IIA 66 Placebo Controlled Study 65 Decitabine 65 Patients Suffering 65 Golimumab 65 Regimens 65 Estrogen Therapy 65 Intravenous Immunoglobulin 65 Double Blind Randomized 65 Drug Regimen 65 Potentially Fatal 65 Fixed Dose Combination 65 Monoclonal Antibodies 65 Dose Ranging 65 Pafuramidine 65 Virologic 65 Serious Infections 65 Initiates Clinical Trials 65 Therapeutic Agents 65 Shown Effective 65 Presents Positive Preclinical 65 Immunosuppression 65 Pandemic Flu Vaccine 65 Chemotherapeutic Agents 65 Commence Phase 65 Randomized Double blind 65 Breast Cancer Recurrence 65 Chronic Sinusitis 65 Chronic Renal Failure 65 Lanthanum Carbonate 65 Lung Cancers 65 Initiated Phase 65 J Clin 65 Pharmacodynamics 65 Viral Load 65 Long Term Outcomes 65 Commences Phase 65 Randomized Double Blind Placebo 65 Genital Herpes 65 Oral Fluid 65 Stent Restenosis 65 Contrast Agents 65 Mg Uk 65 Immunologic 65 Maleate 65 Allergic Reactions 65 Treatment Naive HIV 65 Receptor Antagonist 65 Severe Asthma 65 Renal Function 65 Pneumococcal Conjugate Vaccine 65 Percutaneous Tibial Nerve Stimulation 65 Oral Interferon 65 Treatment Reduces 65 Randomized Phase II 65 Migraine Treatment 65 Cannabinoid 65 Diabetic Foot Ulcer 65 Metastatic Renal Cell Carcinoma 65 Anti Inflammatory 65 Vaccine Trial 65 Renal Impairment 65 Initiates Phase 65 Liver Failure 65 Efficacy Results 65 atazanavir sulfate 65 Antiplatelet 65 Therapeutic Efficacy 65 pan HDAC inhibitor 65 Safety Tolerability 65 Cinacalcet 65 Treatment Resistant 65 HCV Genotype 65 Seasonal Influenza 65 Darinaparsin 65 Darunavir 65 Elagolix 65 Thrombotic 65 Preclinical Studies 65 Initiates Phase 2b 65 OSMOPREP TM 65 Eluting Stent 65 alfa 2a 65 Stent Implantation 65 Genes Involved 65 Bipolar Mania 65 Anidulafungin 65 Prostate Cancer Patients 65 Diagnostic Tests 65 Bosutinib 65 Test Detects 65 Clinical Trial Enrollment 65 Cytotoxic 65 Clinical Evaluation 65 DOR BioPharma Announces 65 Telaprevir VX 65 Hepatitis C Infection 65 Immune Therapy 65 Pandemic Influenza Vaccine 65 Recombinant Protein 65 Investigational Oral 65 Multicenter Trial 65 Thromb Haemost 65 Enlarged Prostate 65 GRAS Status 65 Antiretroviral Therapy 65 Potent Inhibitor 65 Vaginal Gel 65 Prospective Randomized 65 Eculizumab 65 MEK Inhibitor 65 Therapeutic Competitors Companies 65 Avian Influenza Vaccine 65 Myelofibrosis 65 AASLD Meeting 65 Ecallantide 65 Cutaneous T 65 Chronic Bronchitis 65 C1 Inhibitor 65 Radiation Induced 65 Ridaforolimus 65 Dalbavancin 65 Anti Angiogenesis 65 Significantly Improves 65 Tiotropium 65 Cervical Cancer Vaccine 65 REYATAZ ® 65 evaluating tivozanib 65 Phase III Pivotal 65 Entry Inhibitor 65 Progenitor Cells 65 Novel Vaccine 65 Bioequivalence 65 Randomized Controlled Trials 65 Ondansetron Injection USP 65 Pharmacodynamic 65 Hemodialysis Patients 65 Virus Infection 65 Antibiotic Treatment 65 Presents Preclinical 65 Hepatitis C Treatment 65 Suicidality 65 Saquinavir 65 Medoxomil 65 Receives Complete Response 65 Platelet Inhibition 65 Anticancer Agents 65 Novel Inhibitor 65 Neuroendocrine Tumors 65 Arch Neurol 65 Liver Injury 65 Castration Resistant Prostate Cancer 65 Adenoma 65 Diabetic Neuropathic Pain 65 Earns Milestone Payment 65 Osteoarthritis Patients 65 Patent Covering 65 Initiate Clinical Trial 65 Metastatic Prostate Cancer 64 Taro Receives 64 Gastrointestinal Disorders 64 aripiprazole Abilify 64 Neoadjuvant Chemotherapy 64 Resubmission 64 Boceprevir 64 Subtypes 64 Receive Milestone Payment 64 Advanced Colorectal Cancer 64 lucinactant 64 Localized Prostate Cancer 64 Drug Coated Stent 64 Pyridorin TM 64 Therapeutic Antibodies 64 Oral Formulation 64 Hematological 64 Myelodysplastic Syndrome MDS 64 Antiretroviral 64 Skeletal Muscle 64 HCV Infection 64 Topline Results 64 Refractory Angina 64 Advanced Solid Tumors 64 Antimicrobial Coating 64 Adjuvanted 64 Receptor Agonist 64 Antigen Specific 64 Eur J 64 Certolizumab 64 FOLOTYN ® 64 Allogeneic 64 Postmenopausal Osteoporosis 64 Cardiovascular Outcomes 64 Study Demonstrates 64 lexidronam injection 64 Doripenem 64 Multiple Ascending Dose 64 Muscle Wasting 64 CHMP Opinion 64 Protein Involved 64 Nasal Powder 64 Cholesterol Drugs 64 CALGB # [002] 64 Inhaled Nitric Oxide 64 Capecitabine 64 Advanced Renal Cell 64 Targeted Therapy 64 Transdermal Delivery 64 Patients Undergoing 64 Metabolic Disorder 64 Quadrivalent 64 Receives Positive Opinion 64 Systematic Review 64 Clinically Significant 64 Releasing Factor 64 Skin Lesions 64 Liprotamase 64 Desvenlafaxine 64 Asthma Treatment 64 Poster Discussion 64 Fulvestrant 64 Erectile Dysfunction Drug 64 Receives SFDA Approval 64 Therapeutic Monoclonal Antibodies 64 Topical Treatment 64 Newly Diagnosed 64 Valopicitabine 64 Malignant Melanoma 64 Submits Response 64 Oral Laquinimod 64 BARACLUDE ® 64 Immune Mediated 64 Maribavir 64 Knee Osteoarthritis 64 Antithrombin 64 Premature Infants 64 TO AVOID PREGNANCY WHILE 64 Atypical Hemolytic Uremic Syndrome 64 Clin Oncol 64 Carotid Stenting 64 Anti Infective 64 Prognostic Significance 64 Long Term Survival 64 ANDA Filing 64 Hypercholesterolemia 64 Prospective Multicenter 64 PKC# 64 Pharmacyclics Announces 64 Cardiovasc 64 Clinical Trial Evaluating 64 Curr Opin 64 BioSante Pharmaceuticals Reports 64 Develop Novel 64 Significant Improvement 64 Hemorrhagic Stroke 64 methylnaltrexone bromide 64 Respiratory Infections 64 oral prodrug 64 vapreotide acetate 64 Diabetic Macular Edema 64 Anticancer Agent 64 Novel Anti Inflammatory 64 Remission Maintenance 64 telomerase therapeutic 64 Generic Version Of 64 Aloxi ® 64 TYGACIL 64 Weight Loss Drug 64 Adjunctive 64 BioElectronics Announces 64 Sangamo BioSciences Announces 64 Announces Tentative Approval 64 Interferon Alfa 64 Viral Infections 64 FDA Warns Against 64 J Pediatr 64 Secondary Hyperparathyroidism 64 Non Inferiority 64 Nilotinib 64 Diabetic Patients 64 Pivotal Phase II 64 Universal Flu Vaccine 64 Viral Suppression 64 Cholesterol Lowering 64 Treatment Naive 64 Bone Metastases 64 non nucleoside inhibitor 64 Therapeutic Competitors Report 64 BARACLUDE R 64 Preclinical Efficacy 64 Replacement Therapy 64 Guidelines Recommend 64 Androgen Deprivation Therapy 64 Vaccine Shows Promise 64 Melphalan 64 Second Pivotal Phase 64 Licenses Novel 64 Liver Toxicity 64 Antipsychotic Medications 64 Renal Anemia 64 investigational oral inhibitor 64 Safinamide 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 Naive Patients 64 Chronic Myeloid Leukemia 64 Randomized Phase III 64 Anti CD# Antibody 64 Lung Cancer Trial 64 Oral Mucositis 64 Anticancer Compound 64 Lung Injury 64 CCX# B 64 Stem Cell Treatment 64 Chemoradiation 64 Dengue Virus 64 abacavir Ziagen 64 Mouse Models 64 Diamyd Medical Diamyd 64 Relapsed Refractory Multiple Myeloma 64 Clinical Study Shows 64 Drug Maker 64 HCV SPRINT 64 Gets FDA Clearance 64 Brentuximab Vedotin SGN 64 Antiplatelet Therapy 64 Dose Finding 64 Phospholipase A2 64 Blinatumomab 64 humanized monoclonal 64 Positive Opinion 64 Lowers Risk 64 familial amyloidotic polyneuropathy FAP 64 HER2 Positive Breast Cancer 63 Antiepileptic Drug 63 Submits IND 63 Haemophilus b Conjugate 63 Inhalation Solution 63 Telithromycin 63 Announces Poster Presentations 63 GATTEX TM 63 Significant Improvements 63 Combination Vaccine 63 Budesonide 63 Inflammatory Disease 63 ara C 63 Bazedoxifene 63 Nuvelo Announces 63 Lipid Levels 63 Randomized Controlled 63 Statin Drugs 63 Versus Placebo 63 Submits Biologics License Application 63 Genes Linked 63 Antipsychotic Drugs 63 Cancer Treatments 63 Drug Resistant Bacteria 63 Daptomycin 63 Prostate Cancer Treatment 63 Minimally Invasive Treatment 63 Anthrax Vaccine 63 Slows Progression 63 J Am Acad 63 Molecular Diagnostic Test 63 ALN HPN 63 TNF Blockers 63 Annu Rev 63 Pivotal Clinical Trial 63 Survival Rates 63 LENALIDOMIDE 63 Testosterone Gel 63 Therapeutic Effects 63 Sunesis Pharma 63 Lubiprostone 63 Files Investigational 63 Calcium Acetate 63 Sirolimus Eluting 63 Antibiotic Use 63 Lymphocytic 63 ORAL Sync 63 Prove Effective 63 Oritavancin 63 Reminyl galantamine 63 Pegloticase 63 Demonstrates Potential 63 Stakeholder Opinions 63 agonistic human 63 Advanced Ovarian Cancer 63 Receptor Antagonists 63 Suppl. 63 sunitinib Sutent ® 63 Postmenopausal Women 63 Rotavirus Vaccines 63 Antiviral Agents 63 Free Full Text 63 Stent Thrombosis 63 Neuroprotective Effects 63 Patents Covering 63 Preterm Labor 63 Tumor Progression 63 Vitrasert R 63 Improve Diagnosis 63 Immunosuppressant 63 IN PATIENTS WITH 63 Randomized Study 63 Embolic Protection 63 Peginterferon alfa 2b 63 Bird Flu Vaccine 63 CNS Disorders 63 Clinical Outcomes 63 Immune Cells 63 Limb Ischemia 63 Effective Than 63 Sustained Release 63 Adverse Effects 63 Meningitis Vaccine 63 LymphoStat B TM 63 Catheter Ablation 63 Hematopoietic Stem Cells 63 Hepatitis C Patients 63 Postdoctoral Position 63 Autoimmune Disease 63 ergot derivatives 63 Prolongs Life 63 Inhibits 63 Omacetaxine 63 Anemia Drugs 63 preclinical efficacy 63 Cancer Vaccines 63 AVONEX ® 63 Seasonal Flu Vaccine 63 Juvenile Idiopathic Arthritis 63 Denufosol 63 Multidrug Resistant 63 J Allergy Clin 63 FDA Approvable Letter 63 Reduces Risk 63 Anti Malarial 63 Non Responders 63 Onyx Pharmaceuticals Announces 63 Antibacterials 63 Linezolid 63 Pharmacokinetics 63 Carbidopa Levodopa 63 interferon gamma 1b 63 Endometrial Cancer 63 Experimental Vaccine 63 Emerging Therapies 63 Bacteremia 63 Colorectal Adenomas 63 Mimetics 63 Phase Ib II 63 Randomized Controlled Trial 63 Nat Rev 63 Osteoporosis Drugs 63 Peginterferon Alfa 2b 63 Vivo Efficacy 63 Blood Pressure Lowering 63 Epilepsy Drugs 63 Tanespimycin 63 Interferon beta 1a 63 Blood Clotting 63 Cell Transplants 63 Approvable 63 Respiratory Syncytial Virus RSV 63 Androxal TM 63 Million Doses 63 Combination Therapies 63 Regeneron Pharma 63 Susceptibility Testing 63 Lacosamide 63 Virus Linked 63 Symptom Relief 63 Recurrent Breast Cancer 63 #:#-# [031] 63 Menopausal Symptoms 63 Chronic Heart Failure 63 Completes Dosing 63 Relapsing Remitting Multiple Sclerosis 63 Therapeutic Targets 63 FDA Approves Drug 63 Civacir 63 administered concomitantly 63 Cardiac Function 63 Serious Adverse Events 63 Reduced Risk 63 Decompensated Heart Failure 63 Angioedema 63 Rabies Vaccine 63 Betaferon R 63 Newly Diagnosed Patients 63 Soft Tissue Sarcoma 63 KRN# 63 ritonavir boosted 63 Adenoviral 63 Malignant Glioma 63 Sipuleucel T 63 Cognitive Impairment 63 Tuberculosis Vaccine 63 Albuferon TM 63 Paclitaxel Carboplatin 63 Pharmacokinetic 63 XL# XL# 63 Urinary Incontinence 63 ST Elevation Myocardial 63 Topical Gel 63 Aripiprazole 63 Diagnostic Criteria 63 Statin Therapy 63 phase III isavuconazole 63 Adalimumab 63 Myocardial Ischemia 63 Telik Announces 63 Sandostatin R 63 Isavuconazole 63 Vitrasert ® 63 REG2 63 Adverse Event 63 Solid Tumors 63 Data Indicate 63 Sustiva efavirenz 63 Phase 2a Study 63 Announces FDA Clearance 63 Commonly Prescribed 63 abacavir sulfate lamivudine 63 Nanoemulsion 63 Desloratadine 63 rasagiline tablets 63 Female Sexual Arousal 63 Zorbtive TM 63 Trial Halted 63 BAL# [002] 63 Nonclinical 63 miconazole Lauriad ® 63 Asthma Medication 63 Pneumococcal Disease 63 acetonide FA 63 Testosterone Patch 63 Smooth Muscle 63 Node Positive 63 Aneurysm Repair 63 alpha 2a 63 FDA Clearance 63 Gene Linked 63 Randomized Comparison 63 Saforis 63 Liver Damage 63 Multicenter Study 63 NASDAQ AVNR 63 Pharmaceuticals Initiates 62 Virus Vaccine 62 Neulasta ® 62 Diabet Med 62 Ovarian Cancer Patients 62 Cetrorelix 62 Transplant Patients 62 Int J